RT Journal Article
SR Electronic
T1 Kleine Levin syndrome is associated with birth difficulties and genetic variants in the TRANK1 gene loci
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.08.20249006
DO 10.1101/2021.01.08.20249006
A1 Ambati, Aditya
A1 Hillary, Ryan
A1 Leu-Semenescu, Smaranda
A1 Ollila, Hanna M.
A1 Lin, Ling
A1 During, Emmanuel
A1 Farber, Neal
A1 Rico, Thomas J
A1 Faraco, Juliette
A1 Leary, Eileen
A1 Goldstein-Piekarski, Andrea
A1 Huang, Yu-Shu
A1 Han, Fang
A1 Sivan, Yakov
A1 Lecendreux, Michel
A1 Dodet, Pauline
A1 Honda, Makoto
A1 Gadoth, Natan
A1 Nevsimalova, Sona
A1 Pizza, Fabio
A1 Kanbayashi, Takashi
A1 Adrados, Rosa Peraita
A1 Leschziner, Guy
A1 Hasan, Rosa
A1 Canellas, Francesca
A1 Kume, Kazuhiko
A1 Daniilidou, Makrina
A1 Bourgin, Patrice
A1 Rye, David
A1 Vicario, José L
A1 Högl, Birgit
A1 Hong, Seung Chul
A1 Plazzi, Guiseppe
A1 Mayer, Geert
A1 Landtblom, Anne Marie
A1 Dauvilliers, Yves
A1 Arnulf, Isabelle
A1 Mignot, Emmanuel
YR 2021
UL http://medrxiv.org/content/early/2021/01/16/2021.01.08.20249006.abstract
AB Kleine-Levin Syndrome (KLS) is a rare disorder characterized by severe episodic hypersomnia, with cognitive impairment accompanied by apathy or disinhibition. Pathophysiology is unknown, although imaging studies indicate decreased activity in hypothalamic/thalamic areas during episodes. Familial occurrence is increased, and risk is associated with reports of a difficult birth. We conducted a worldwide case-control genome wide association study in 673 KLS cases collected over 14 years, and ethnically matched 15,341 control individuals. We found a strong genome-wide significant association (OR=1.48,rs71947865,p=8.6×10−9) with 20 single nucleotide polymorphisms encompassing a 35kb region located in the 3’ region of TRANK1 gene, previously associated with bipolar disorder and schizophrenia. Strikingly, KLS cases with TRANK1 rs71947865 variant had significantly increased reports of a difficult birth. As perinatal outcomes have dramatically improved over the last 40 years, we further stratified our sample by birth years and found that recent cases had a significantly reduced TRANK1 rs71947865 association. While theTRANK1 rs71947865 association did not replicate in the entire follow-up sample of 171 KLS cases, the TRANK1 rs71947865 was significantly associated with KLS in the subset follow-up sample of 59 KLS cases who reported birth difficulties (OR=1.54;p=0.01). Genetic liability of KLS as explained by polygenic risk scores was increased (pseudo r2=0.15;p<2.0×10−22 at p=0.5 threshold) in the follow-up sample. Pathway analysis of genetic associations identified enrichment of circadian regulation pathway genes in KLS cases. Our results suggest links between KLS, behavioral rhythmicity, and bipolar disorder, and indicates that the TRANK1 polymorphisms in conjunction with reported birth difficulties may predispose to KLS.Significance Statement Genetic markers in TRANK1 gene and its vicinity have been weakly associated with bipolar disorder and schizophrenia (10% increased risk). We found that the same polymorphisms are associated with Kleine-Levin Syndrome (50% increased risk), a rare sleep disorder characterized by recurrent episodes of severe hypersomnia and cognitive abnormalities. Response to lithium treatment are suggestive of a pathophysiological overlap between KLS and bipolar disorder. The study also shows that variants in the TRANK1 gene region may predispose to KLS when patients have had a difficult birth, suggesting that TRANK1 gene region modulate newborns’ response to brain injury, with consequences for mental and neurological health in adulthood. Another possibility may be that the polymorphism impact birth and KLS.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe thank countless staff members, clinicians, patients, and patient advocates who are not listed here and have provided material and logistic support over decades for these 15 yearlong studies. The study was primarily funded by the Kleine-Levin Syndrome Foundation (KLSF, 2003-2020) and by NIH 1R01MH080957 (2007-2013) to EM. The French Kleine-Levin Syndrome research program is financed by a grant to IA (PHRC 070138) from the French Ministry of Health. HMO has been supported by the Academy of Finland (#309643), Yrjo Jahnsson Foundation and Oskar Oflund Foundation. Computing for this project was performed on the Stanford Genomics cluster supported by NIH 1S10OD023452-01. We would like to thank the Stanford Research Computing Center for providing computational resources and support that contributed to these research results.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Stanford University IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll genotyping calls can be requested by contacting the corresponding author.